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Background: Orthostatic hypotension (OH) caused by autonomic dysfunction is a
common symptom in older people and patients with idiopathic rapid eyemovement sleep
behavior disorder (iRBD). The orthostatic challenge test is a standard autonomic function
test that measures a decrease of blood pressure during a postural change from supine
to standing positions. Although previous studies have reported that changes in heart rate
variability (HRV) are associated with autonomic dysfunction, no study has investigated
the relationship between HRV before standing and the occurrence of OH in an orthostatic
challenge test. This study aims to examine the connection between HRV in the supine
position and the occurrence of OH in an orthostatic challenge test.
Methods: Wemeasured the electrocardiograms of patients with iRBD and healthy older
people during an orthostatic challenge test, in which the supine and standing positions
were held for 15min, respectively. The subjects were divided into three groups: healthy
controls (HC), OH-negative iRBD [OH (–) iRBD], and OH-positive iRBD [OH (+) iRBD].
HRV measured in the supine position during the test were calculated by time-domain
analysis and Poincaré plots to evaluate the autonomic dysfunction.
Results: Forty-two HC, 12 OH (–) iRBD, and nine OH (+) iRBD subjects were included.
HRV indices in the OH (–) and the OH (+) iRBD groups were significantly smaller than
those in the HC group. The multivariate logistic regression analysis for OH identification
for the iRBD groups showed the model whose inputs were the HRV indices, i.e., standard
deviation 2 (SD2) and the percentage of adjacent intervals that varied by more than 50ms
(pNN50), had a receiver operating characteristic curve with area under the curve of 0.840,
the sensitivity to OH (+) of 1.000, and the specificity to OH (–) of 0.583 (p = 0.023).
Sumi et al. Resting HRV Associated With OH
Conclusions: This study showed the possibility that short-term HRV indices in the
supine position would predict subsequent OH in iRBD patients. Our results are of clinical
importance in terms of showing the possibility that OH can be predicted using only HRV
in the supine position without an orthostatic challenge test, which would improve the
efficiency and safety of testing.
Keywords: orthostatic hypotension, OH, rapid eye movement sleep behavior disorder, RBD, heart rate variability,
HRV, Poincaré plot, autonomic dysfunction
INTRODUCTION
Orthostatic hypotension (OH) is a major health concern in
older people, affecting approximately one-third to two-thirds
of them (1–3). A recent systematic review and meta-analysis
found that OH is associated with falls in older people (4). OH
symptoms, which include dizziness, titubation, blurry vision,
syncope, nausea, and falls, occur due to temporary cerebral
hypoperfusion and sympathetic hyperactivity (5). In particular, it
is important to prevent falls associated with OH because injuries
caused by falls may significantly impair quality of life.
OH is defined as a persistent decrease of systolic blood
pressure (BP) ≥20mm Hg, a persistent decrease of diastolic
BP ≥10mm Hg, or a decrease in systolic BP to <90mm Hg
within 3min of standing or head-up tilt, or the manifestation
of any OH clinical symptoms (2, 6, 7). It has been reported
that a drop in BP at 1min after standing from supine is
important because it is associated with future adverse outcomes,
including falls, fractures, and syncope (8). The American Society
of Hypertension recommends measuring BP at 1 and 3min after
standing to detect BP decrease within 3min (9). While aging,
drug side effects, and dehydration can cause OH, autonomic
dysfunction is one of the most important factors of OH, but it
is often difficult to be aware of it (5, 10).
Rapid eye movement (REM) sleep behavior disorder (RBD)
is REM parasomnia characterized by dream-enacting behaviors
(11). Although RBD is widespread among patients with
neurodegenerative disorders, such as Parkinson’s disease (PD),
dementia with Lewy bodies (DLB), or multiple system atrophy
(MSA) (12–17), RBD is often a precursor of the clinical
appearance of PD, DLB, or MSA. The idiopathic form without
any neurological disorder is called idiopathic RBD (iRBD) (18).
Although some iRBD patients have stayed disease-free for more
than 10 years after being diagnosed with RBD (19), most
iRBD patients phenoconvert to synucleinopathy over time (20),
and it has been reported that severe cardiovascular autonomic
dysfunction in iRBD is associated with phenoconversion to
DLB (21).
In order to prevent falls of iRBD patients caused by OH,
the severity of OH needs to be evaluated. One standard test for
evaluating the severity of OH is the orthostatic challenge test,
which usually takes place in clinics or hospitals (3). In the test,
a subject is asked to change his/her position from supine to
standing, and his/her BP is measured at fixed intervals during
both the supine and the standing positions. Since the orthostatic
challenge test requires medical staff to ensure subject safety, it
is difficult to perform it in daily life. Thus, we should develop a
simple alternative method for evaluating OH severity that can be
easily performed even in daily life.
Autonomic dysfunction and OH are common among older
people, particularly patients with α-synucleinopathies, such as
PD, DLB, and MSA (10, 22). It has been reported that the more
severe motor symptoms become, the more severe the autonomic
dysfunction becomes in patients with PD (23).
The pathology of RBD involves brain regions that are
responsible for the autonomic nervous system as well as
the brainstem which regulates REM sleep (24, 25). Various
clinical studies have reported that autonomic dysfunction
is associated with iRBD. According to a multicentral study
involving 24 institutes, 156 out of 531 patients with iRBD
(29.4%) had orthostatic symptoms (26). In addition, the uptake
of 123I-metaiodobenzylguanidine (123I-MIBG) in the iRBD
patients tends to decrease, which indicates cardiac sympathetic
denervation (27, 28). Thus, patients with iRBD potentially
have autonomic dysfunction, and the severity of autonomic
dysfunction may be utilized as a proxy variable for assessing
OH severity.
Although various methods for evaluating the severity of
autonomic dysfunction have been proposed, they have some
problems. Interviews or questionnaires such as the Scales
for Outcomes in Parkinson’s Disease-Autonomic questionnaire
(SCOPA-AUT) (23) may overlook OH symptoms of which
patients are not aware. 123I-MIBG is a quantitative test of
autonomic dysfunction; however, it uses a radioactive substance
and is expensive.
In this work, we focus on heart rate variability (HRV) which
is spontaneous beat-to-beat oscillation in the R-R interval (RRI)
of an electrocardiogram (ECG) and reflects the autonomic
nervous function (29). According to research using RRI data
collected during sleep by means of polysomnography (PSG),
HRV indicators of patients with PD and iRBD are different
from healthy controls (30–32), which indicates that patients
with PD and iRBD have autonomic dysfunction. However,
studies on HRV during an OH test of iRBD patients have not
been performed.
We assumed that signs of autonomic dysfunction associated
withOH appear even when in the supine position before standing
in the orthostatic challenge test. Therefore, we conducted the
orthostatic challenge test with ECG measurement for patients
with iRBD and healthy older people in order to investigate
the relationship between HRV in the supine position and the
occurrence of OH. In addition, we discuss the possibility of the
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use of HRV analysis as an alternative method to the orthostatic
challenge test for evaluating OH severity.
METHODS
Subjects
Participants in this study consisted of healthy subjects and
patients with iRBD. The details of this study were explained
to them and written informed consent was obtained from each
subject. In addition, the protocol was approved by the ethical
committee at the Shiga University of Medical Science (R2017-
199). Healthy subjects and patients with iRBD were recruited
between December 2017 and August 2019.
We recruited healthy subjects over 60 years of age and without
history of autonomic dysfunction.
In this study, patients who satisfied diagnostic criteria of RBD
according to the 3rd edition of the International Classification
of Sleep Disorders (ICSD-3) were recruited from among patients
who visited the Shiga University of Medical Science. PSG was
performed on all of the patients; who were then diagnosed with
RBD. In order to focus on iRBD (18), patients with PD (33), DLB
(34), or MSA (35) were excluded. Patients on antidepressants or
with severe sleep apnea were also excluded because they might
have symptoms mimicking RBD, such as medication-related
dream enactment behaviors and apnea-related behaviors (36, 37).
Patients with a history of cerebral infarction were also excluded.
A total of 60 healthy subjects and 29 iRBD patients were
enrolled. One healthy subject was excluded because of a history
of autonomic failure. Since a comorbidity of arrhythmia could
affect the results of HRV analysis, 9 healthy participants and 3
iRBD patients with the comorbidity of arrhythmia were excluded
(Figure 1).
The orthostatic challenge test (the details are described in
the “Experimental Protocol” section) was conducted on the
remaining 50 healthy subjects and 26 iRBD patients. One healthy
subject who did not maintain the standing position during the
standing phase was excluded, and 3 healthy subjects who satisfied
the OH criteria were also excluded (the details of OH criteria are
described in “Orthostatic Hypotension Criteria and Grouping”
in the “Orthostatic Challenge Test” section). One iRBD patient
to whom the examiner failed to attach devices was also excluded.
The adaptation of the Hampel and the quotient filters (38, 39)
resulted in the exclusion of 4 healthy subjects and 4 patients
with iRBD.
Finally, 42 healthy controls (HC) and 21 patients with iRBD
[12 OH (–) iRBD and 9 OH (+) iRBD] were included in
this study. The definition of the subject grouping are described
in “Orthostatic Hypotension Criteria and Grouping” in the
“Orthostatic Challenge Test” section.
Experimental Protocol
The study consisted of a clinical interview and an orthostatic
challenge test. The participants were instructed not to ingest
FIGURE 1 | Flowchart of subject enrollment. iRBD, idiopathic rapid eye movement sleep behavior disorder; OH, orthostatic hypotension; HRV, heart rate variability.
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alcohol, caffeine, or to smoke the night before the experiment
because these substances could affect the autonomic nervous
system (40). The experiment was conducted between 2 p.m. and 4
p.m. to minimize the effect of the circadian rhythm on HRV (41).
Subjects were instructed to finish meals 2 h before the start of the
experiment (42).
Clinical Interview
The subjects were interviewed regarding their past histories
including arterial hypertension, coronary artery disease,
myocardial infarction, and diabetes mellitus, as well as their
smoking habits, which could affect BP dynamics and autonomic
nervous functions (43). Interviews about medication which
could affect BP or HRV, including beta-blockers, calcium
channel blockers, diuretics, angiotensin-converting-enzyme
(ACE) and angiotensin II type 1 (AT II) inhibitors, organic
nitrates, arrhythmic medications, atropine, scopolamine,
atenolol, metoprolol, loop diuretics, monoamine oxidase
inhibitors, antipsychotics, antidepressant agents, phenothiazine,
phosphodiesterase type 5 inhibitors, parkinsonism agents,
barbiturates, anesthetics, opioids, muscle relaxants, vincristine,
or doxorubicin were also conducted (7, 43–49). The cognitive
functions of the subjects were evaluated using the Mini-Mental
State Examination (MMSE), which is a screening tool for
dementia with a cut-off score of 23/24 (maximum score of 30)
(50). The participants were asked to answer the REM sleep
behavior disorder screening questionnaire (RBDSQ), which
consists of 13 questions (maximum possible score = 13), to
assess RBD symptoms such as nocturnal movements, injuries,
and motor behavior during the night (51, 52). In this study, the
Japanese version of the RBDSQ (RBDSQ-J) was used (53).
In addition, patients with iRBD were asked about the duration
of their RBD disease, the onset of which was confirmed by
family members.
Orthostatic Challenge Test
In order to evaluate behavior in daily life, an active standing
test called the orthostatic challenge test was performed instead
of passive standing tests such as the tilt test (3). The orthostatic
challenge test was performed in our laboratories, in which the
temperature and humidity were set to 23.0 ± 2.0◦C [mean
± standard deviation (SD)] and 35.2 ± 12.7 % (mean ±
SD), respectively.
Measurement Devices
A wearable RRI sensor (T. Yamakawa Lab, wireless R-R monitor
Bluetooth LE model ver 0.7) was used for RRI measurement
(Figure 2) (54). This sensor is able to record ECG signals at
a 1,000Hz sampling rate and to measure RRI automatically
without requiring any special skills. The measured RRI data were
sent to a Nexus5X smartphone [Google, LG. Operating system
Android 6.0 (Marshmallow)] via Bluetooth Low Energy (BLE).
The smartphone was placed in a running pouch attached to the
back of the waist and the received RRI data were stored by a
custom-made smartphone app (Figure 2) (55). The RRI error
handling procedure in this study is described in the “Heart Rate
Variability Analysis” section.
FIGURE 2 | Smartphone Nexus 5X and wearable RR intervals sensor. The RRI
data acquired by the wearable RRI sensor was sent to the smartphone
application in real time. This figure shows the heart rate 66 calculated from the
RRI at that time. In this experiment, the electrodes of the wearable RRI sensor
were attached to the three poles of the trunk of the subject, just as in a normal
electrocardiogram. The smartphone was in a running pouch attached to the
back of the waist of the subject. RRI, RR intervals.
In addition, BP and pulse rate (PR) were measured
with a digital brachial BP monitor HEM-7500 (OMRON
HEALTHCARE Co., Ltd., Japan). The BP monitor was attached
to the left upper arm of the participant so that the cuff of
the sphygmomanometer was at heart level. When the examiner
pressed a button on the sphygmomanometer, the cuff was
automatically pressurized and depressurized to record systolic BP
(sBP), diastolic BP (dBP), and PR.
Orthostatic Challenge Protocol
The orthostatic challenge test was composed of two phases:
supine- and standing-position phases (Figure 3). Before the test,
the participants were equipped with the wearable RRI sensor,
the smartphone, and the sphygmomanometer, and instructed to
lie in bed at about 40 cm from the floor. In addition, they were
instructed to avoid talking and not to fall asleep during the test.
After checking the device operation in the supine position
(>2min), the measurements of BP and PR began, they were
performed four times with 3-min intervals. After being in the
supine position for 15min, the participants were instructed
to quickly stand up and to keep their standing position for
15min. After standing for 1min, BP and PR measurement
was performed once per min for 15min. The examiner
carefully monitored the safety of the participant during the
test. After the orthostatic challenge test, the examiner, by
asking the participants, confirmed the presence/absence of the
following symptoms: dizziness, titubation, blurry vision, syncope,
or nausea.
Orthostatic Hypotension Criteria and Grouping
The average of five BP and PR measurements of each participant
in the supine position was defined as the baseline. The orthostatic
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FIGURE 3 | Orthostatic challenge protocol. Black circles (•) show when blood pressure and pulse rate were measured. The measurements were done every 3min
when in the supine position, and every 1min when in the standing position. Ten min worth of RRI data in the supine position were analyzed for heart rate variability,
which were divided into two segments (segment 1: 6–10min and segment 2: 11–15min).
challenge test was determined to be positive when the participant
satisfied one of the following conditions: (1) decrease of sBP
≥20mmHg, or decrease of dBP≥10mmHg in comparison with
the baseline BP at 1 or 3min after standing, (2) a decrease in
systolic BP to <90mm Hg, or (3) manifestation of any clinical
symptom including falling, dizziness, blurry vision, syncope, and
nausea (2, 6, 7, 9). However, for the patients with baseline sBP
≥160mm Hg, the criterion of a decrease of sBP ≥30mm Hg
was applied thereto, based on criteria proposed by the American
Society of Hypertension (3, 9). In all other cases, the orthostatic
challenge test was determined to be negative.
In patients with iRBD, those whomet the orthostatic challenge
test criteria were defined as “OH (+) iRBD,” and those who did
not meet the criteria were defined as “OH (–) iRBD.” Among
healthy subjects, those who did not meet the OH criteria were
defined as “HC (healthy control);” on the other hand, those who
met the OH criteria were excluded because they might have
potential autonomic nervous dysfunction (Figure 1).
Heart Rate Variability Analysis
The HRV data extracted from the RRI data measured when in
the supine position were analyzed (Figure 3). Data from the
first 5min in the supine position were excluded from the HRV
analysis because RRI for the first 5min may have been impacted
by the posture change from the sitting to the supine position (56).
Thus, data from the remaining 10min were analyzed, which were
named “whole period” and divided into two segments (segment
1: 6–10min and segment 2: 11–15min). In the manuscript,
the results for segment 2 were mainly described because the
subjects had been in the supine position for a long time; the
results for segment 1 and the whole period are shown in
the Supplementary Table 1.
Incidental arrhythmias such as premature atrial contractions
(PAC) or premature ventricular contractions (PVC) are often
observed in continuous ECG measurements of elderly people,
although arrhythmias are not identified in short-term ECG
examination. A high proportion of PAC and PVC in the elderly
has been reported (57, 58); thus, it is necessary to filter ectopic
RRI caused by PAC or PVC to suppress the influence of such
ectopic RRIs on the HRV analysis (59). Therefore, this study
adopted two HRV filtering methods: the Hampel filter and the
quotient filter (38, 39). RRIs that deviate from the 3-σ range,
which refers to data within three standard deviations from a
mean, are detected by means of the Hampel filtering. In addition,
quotient filtering detects significant RRI fluctuations: RRI that
has a 10% or more change than the mean of before and after the
RRI. Additionally, all data recorded from the participant were
removed from the analysis when the sum of the RRIs detected
with these filters became >150 s within the 5-min section (or
300 s within the 10-min section), because reliable analysis of such
ectopic data was difficult.
Because frequency-domain analysis is significantly affected
by incidental arrhythmias, the Poincaré plot and time-domain
analysis were employed in this study (60). The Poincaré plot is
based on a simple scatter of plots where the x value is the nth
RRI and its corresponding y value is the (n + 1)th RRI. A
typical Poincaré plot forms an ellipse with about a 45 tilt, and
the diffusion ranges around the major axis and the minor axis of
the ellipse are defined as the standard deviation 2 and 1 (SD2 and
SD1), respectively. In addition, their ratio is defined as SD1/SD2
(Figure 4).
In addition to the Poincaré plot, time-domain analysis, which
includes the standard deviation of all R-R intervals (SDNN), the
root mean square of successive differences (RMSSD), and the
percentage of adjacent intervals that varied by more than 50ms
(pNN50) was performed.
Various indices of HRV have been reported to be associated
with the sympathetic and the parasympathetic nervous system
(61). For the time-domain analysis, SDNN is influenced by the
sympathetic and the parasympathetic nervous system; pNN50
and RMSSD mainly correlate to the parasympathetic nervous
system. In particular, pNN50 <3% and RMSSD <25ms are
regarded as low parasympathetic activity (62, 63). For the
Poincaré plots, SD1 represents the parasympathetic nervous
function, SD2 is related more strongly to the sympathetic than to
the parasympathetic tone, and SD1/SD2 represents the balance
between the sympathetic-parasympathetic arms (60, 64–66).
Outcome Measurement
The demographic data of the HC, OH (–) iRBD, and OH (+)
iRBD groups were examined. In addition, the experimental data
of these three groups—BP and PR of the baseline and the delta
values at 1 and 3min after standing, and the ratio of clinical
symptoms manifested after standing—were compared. The HRV
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FIGURE 4 | Typical Poincaré plot of RRI. The Poincaré plot was based on a
simple scatter of plots where the x value is nth RRI and its corresponding y
value is the (n + 1)th RRI. Each plot is described in the (RRI n, RRI n + 1)
space. This figure represents the Poincaré plot of a 5-min RRI. The Poincaré
plot typically forms an ellipse with about a 45-degree tilt, and the diffusion
range around the major axis and the minor axis of the ellipse are defined as
SD2 and SD1, respectively. Their ratio is defined as SD1/SD2. RRI, RR
intervals; SD1, standard deviation 1; SD2, standard deviation 2.
features when in the supine position were compared among the
three groups.
Statistical Analysis
For comparison with the three groups, nominal data were
compared using the χ2-test. The normality of the distribution
of the variable was checked by the Shapiro-Wilk test (p <
0.05 was considered statistically significant). Parametric variables
were presented as mean ± SD; non-parametric variables were
presented as the median and interquartile range (IQR). For
the three groups, parametric variables were compared using
one-way analyses of variance (ANOVAs) with Tukey’s post-
hoc analysis followed by Bonferroni correction; non-parametric
variables were compared using the Kruskal-Wallis test and
post-hoc Mann-Whitney test followed by Bonferroni correction.
For comparison with the two groups [OH (–) iRBD and
OH (+) iRBD], parametric variables were compared using
Student’s t-test.
Age and BMI were compared using ANOVAs. Years of
education, a score of MMSE, and a score of RBDSQ-J were
compared using the Kruskal-Wallis test. Gender differences, rate
of comorbidities, and rate of medication usage were compared
using the χ2-test. The disease duration of RBD was analyzed
using the Student’s t-test. In the orthostatic challenge test, BP
and PR of the baseline and the delta values at 1 and 3min after
standing were compared using ANOVAs at each time point.
For the correction for the multiple comparisons, Tukey’s post-
hoc analysis was used for the comparison of multiple groups,
and Bonferroni adjustment was performed for multiple time
points (p < 0.05/3 ≈ 0.017). The ratio of the clinical symptoms
that appeared after standing was assessed using the χ2-test.
In addition, HRV indices when in the supine position were
compared using the Kruskal-Wallis test and post-hoc Mann-
Whitney test followed by Bonferroni correction.
A value of p < 0.05 was considered significant in this study.
For parametric variables, the Cohen’s d effect size index was used
to calculate the pairwise differences. Cohen classified the effect
sizes into small (d = 0.2), medium (d = 0.5), and large (d =
0.8) (67). For non-parametric variables, the effect size r was used
to calculate the pairwise differences. The effect sizes of r were
classified into small (r = 0.1), medium (r = 0.3), and large (r =
0.5) (68).
Next, among the OH (–) iRBD and OH (+) iRBD patients, a
multivariate logistic regression analysis was conducted to focus
on the relationship between the OH (+/–) and HRV indices,
with OH (–) or OH (+) as the dependent variable and HRV
indices (SDNN, RMSSD, pNN50, SD1, SD2, and SD1/SD2) as
the independent variables. The Bayesian information criterion
(BIC) was used to select the appropriate independent variables.
In a model that minimized the BIC, we calculated the area under
the curve (AUC) of the receiver operating characteristic (ROC)
curve, the sensitivity of OH (+), and the specificity of OH (–).
Besides, the value of HRV indices that maximizes Youden’s index
was calculated to determine the optimal cutoff values (69).
These statistical tests were performed using IBM SPSS
Statistics for Macintosh, Version 22.0 (IBM Corp. Armonk, NY).
HRV were evaluated with an HRV Analysis software (Kubios
HRV v.1.1 for Windows, Biomedical Signal Analysis Standard).
RESULTS
Demographics
The demographic data of the included participants are shown
in Table 1. HC, OH (–) iRBD, and OH (+) iRBD subjects were
not significantly different in age, BMI, years of education, or
the scores of MMSE. Since the patients were predominantly
male, reflecting the male-dominant nature of this disease, the sex
proportions were significantly different among the three groups.
The RBDSQ-J scores were significantly different among the
three groups. The RBD disease durations were not significantly
different between OH (–) and OH (+) iRBD groups.
Of the comorbidities that could affect BP or HRV,
there were no significant differences in the promotions of
arterial hypertension, coronary artery disease, and diabetes
mellitus. However, the proportion of myocardial infarction was
significantly higher in the OH (+) iRBD group.
For medications that could affect BP or HRV, calcium
channel blockers, ACE and AT II inhibitors, and organic
nitrates were used by the participants. There was a significant
difference in the proportion of ACE and AT II inhibitor
use. Of the calcium channel blockers, diltiazem may decrease
the low-frequency component of HRV and nifedipine may
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TABLE 1 | Demographic data of healthy controls, OH (–) iRBD, and OH (+) iRBD
groups.
Demographics HC OH (–) iRBD OH (+) iRBD
(n = 42) (n = 12) (n = 9) p
Age (years)a 70.2 ±6.6 74.8 ±6.3 73.2 ±5.3 0.068
Gender (male: female)b 16:26 9:3 8:1 0.005
BMI (kg/m2 )a 22.4 ±3.0 21.6 ±2.6 23.2 ±2.9 0.468
Years of educationc 13.0 (4.0) 16.0 (4.0) 12.0 (4.0) 0.347
MMSEc 29.0 (3.0) 29.0 (4.0) 29.0 (5.0) 0.958
RBDSQ-Jc 1.0 (2.0) 3.0 (2.5) 3.0 (3.0) 0.002
Duration of RBD (years)d – 10.2 ±6.8 9.2 ±6.2 0.748
Comorbiditiesb
Arterial hypertension (n) 9 (21.4%) 4 (33.3%) 3 (33.3%) 0.592
Coronary artery disease (n) 1 (2.4%) 2 (16.7%) 1 (11.1%) 0.165
Myocardial infarction (n) 0 (0.0%) 0 (0.0%) 2 (22.2%) 0.002
Diabetes mellitus (n) 3 (7.1%) 3 (25.0%) 1 (11.1%) 0.222
Medicationb
Calcium channel blockers (n) 6 (14.3%) 3 (25.0%) 3 (33.3%) 0.353
ACE and AT II inhibitors (n) 4 (9.5%) 1 (8.3%) 2 (22.2%) <0.001
Organic nitrates (n) 1 (2.4%) 1 (8.3%) 0 (0.0%) 0.492
ACE, angiotensin-converting-enzyme; AT II, angiotensin II type 1; BMI, body mass index;
HC, healthy control; OH, orthostatic hypotension; iRBD, idiopathic rapid eye movement
sleep behavior disorder; MMSE, Mini-Mental State Examination; RBDSQ-J, rapid eye
movement sleep behavior disorder screening questionnaire Japanese version.
Results are presented with mean ± standard deviation for parametric variables, median
(interquartile range), or percentage in parentheses.





not (45). ACE and AT II inhibitors may increase the low-
frequency component of HRV (44). Nobody used any of the
other medications listed below, which might influence BP or
HRV; arrhythmic medications, atropine, scopolamine, atenolol,
metoprolol, beta-blockers, loop diuretics, monoamine oxidase
inhibitors, antipsychotics, antidepressant agents, phenothiazine,
phosphodiesterase type 5 inhibitors, parkinsonism agents,
barbiturates, anesthetics, opioids, muscle relaxants, vincristine,
or doxorubicin.
As to smoking habit and the use of dopaminergic agonists,
there were few participants (zero or one) in each group of HC,
OH (–), and OH (+) iRBD.
Orthostatic Challenge
The results of the orthostatic challenge test are shown in Figure 5
and Table 2. sBP tended to decrease after standing, in the order
of OH (+) iRBD, OH (–) iRBD, andHC (Figures 5A1,A2). In the
OH (+) iRBD group, sBP decreased remarkably by 28.6mm Hg
on average at 1min after standing, and the trend of decreasing
sBP continued thereafter. dBP increased after standing in HC;
however, it decreased in OH (+) iRBD (Figures 5B1,B2). In
addition, dBP decreased by 11.4mmHg on average at 1min after
standing and the trend of decreasing dBP continued thereafter as
with sBP.
PR increased after standing in all three groups
(Figures 5C1,C2). Although the increase in PR at 1min
after standing was 11.1 beats/min on average in HC, the increase
of PR in OH (+) iRBD was 4.9 beats/min and smaller than that
of HC (p = 0.003). PR in the HC group increased greatly after
standing and then decreased rapidly. Similar changes were not
observed in the OH (+) or OH (–) iRBD groups.
Delta values of BP and PR (written as 1sBP, 1dBP, and 1PR)
and the occurrence of subjective symptoms related to theOH+/–
criteria were compared among the three groups (Table 2). sBP,
dBP, and PR at the baseline were not significantly different among
the three groups. There were statistically significant differences
in 1sBP at 1min (p < 0.001) and at 3min after standing
(p < 0.001), and 1dBP at 1min (p < 0.001) and at 3min after
standing (p < 0.001). Subsequent post-hoc analyses revealed
that 1sBP at 1min after standing in the OH (+) iRBD group
was significantly lower than that in the HC group and OH (–)
iRBD group with large effect sizes (Cohen’s d = 2.585, 2.037,
respectively). Similarly, 1sBP at 3min after standing in the OH
(+) iRBD group was significantly lower than the HC group with
a large effect size (Cohen’s d = 1.727). 1dBP at 1min after
standing in the OH (–) iRBD and OH (+) iRBD groups were
significantly lower than that in the HC group with large effect
sizes (Cohen’s d = 1.057, 2.182, respectively).
Only dizziness was reported in this test as a subjective
symptom in the OH (+) iRBD group (n = 2; 22.2%), and the
incidence of dizziness was significantly different in the three
groups (p = 0.002).
Heart Rate Variability Analysis
The results of the time-domain analysis and the Poincaré
plots for HRV during segment 2 are shown in Table 3, and
those during segment 1 and whole period are shown in
Supplementary Table 1. Examples of Poincaré plots during
segment 2 in the supine position are shown for a single
HC subject, a single OH (–) iRBD subject, and a single OH
(+) iRBD subject in Figure 6. HRV indices were significantly
different among the three groups in time-domain analysis and
the Poincaré plots.
First, as for the time-domain analysis during
segment 2, significant differences in SDNN, RMSSD,
and pNN50 were confirmed among the three groups
(p < 0.001, p = 0.003, 0, 010, respectively). Subsequent
post-hoc analyses revealed that SDNN in the OH (–) iRBD
and the OH (+) iRBD groups were significantly smaller
than that in the HC group with medium and large effect
sizes (r = 0.477, 0.597, respectively); RMSSD in the OH
(–) iRBD and the OH (+) iRBD groups were significantly
smaller than that in the HC group with medium effect sizes
(r = 0.364, 0.358, respectively); and pNN50 in the OH (–)
iRBD group was significantly smaller than that in the HC group
with a medium effect size (r = 0.370).
Second, in terms of the Poincaré plots, there were no
significant differences among the three groups in SD1/SD2;
however, significant differences were confirmed in SD1 and
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FIGURE 5 | Comparison of orthostatic challenge test among healthy controls, OH (–) iRBD, and OH (+) iRBD groups. (A1–C1), absolute changes (mean ± standard
error of the mean); (A2–C2), delta values compared to baseline supine position (mean ± standard error of the mean). BP, blood pressure; HR, heart rate; iRBD,
idiopathic rapid eye movement sleep behavior disorder; OH, orthostatic hypotension. x-axis: base, mean baseline values in supine position; 1–15min, after standing.
SD2 (p = 0.003, p < 0.001, respectively). Subsequent
post-hoc analyses revealed that SD1 in the OH (–) iRBD
and the OH (+) iRBD groups were significantly smaller than
that in the HC group with medium effect sizes (r =
0.367, 0.541, respectively); SD2 in the OH (–) iRBD and
the OH (+) iRBD groups were significantly smaller than that
in the HC group with medium and large effect sizes (r =
0.471, 0.602, respectively).
RRI usually fluctuates and the magnitude of the RRI
fluctuations is represented by SDNN and RMSSD, or visualized
by the Poincaré plot (Figure 3). The results in Table 3 are
visualized in the examples in Figure 6. In the HC group, RRI
fluctuated within a certain range, and the Poincaré plot showed
an oval-like shape (Figure 6A). However, in the OH (–) iRBD
group, RRI fluctuated within a small range, and the Poincaré plot
showed a narrow distribution (Figure 6B) with a smaller median
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TABLE 2 | Results of orthostatic challenge test.
Effect sizes (Cohen’s d)
HC OH (–) iRBD OH (+) iRBD HC– HC– OH (–) iRBD–
(n = 42) (n = 12) (n = 9) p Pairwise differences OH (–) iRBD OH (+) iRBD OH (+) iRBD
Systolic BP (mm Hg)a
Baseline 132.8 ±17.3 135.9 ±16.8 127.9 ±18.5 0.580 N/A −0.181 0.280 0.456
1sBP at 1min after standing −1.0 ±11.2 −12.3 ±8.3 −28.6 ±7.5 <0.001 HC > OH (–) iRBD > OH (+) iRBD 1.068 2.585 2.037
1sBP at 3min after standing 4.3 ±11.1 −3.6 ±7.5 −15.0 ±11.6 <0.001 HC > OH (+) iRBD 0.752 1.727 1.215
Diastolic BP (mm Hg)a
Baseline 79.7 ±8.0 78.7 ±9.2 79.9 ±11.6 0.936 N/A 0.118 −0.023 −0.115
1dBP at 1min after standing 3.7 ±7.1 −3.6 ±5.9 −11.4 ±5.8 <0.001 HC > OH (–) iRBD = OH (+) iRBD 1.057 2.182 1.334
1dBP at 3min after standing 5.9 ±6.0 0.9 ±4.7 −5.9 ±4.9 <0.001 HC > OH (+) iRBD 0.879 2.022 1.411
Pulse rate (beats/min)a
Baseline 63.6 ±7.8 62.9 ±7.8 71.0 ±14.1 0.055 N/A 0.100 −0.805 −0.819
1PR at 1min after standing 11.1 ±5.7 6.2 ±6.7 4.9 ±3.6 0.003 HC > OH (+) iRBD 0.818 1.135 0.234
1PR at 3min after standing 7.0 ±5.1 6.0 ±6.3 5.4 ±3.8 0.646 N/A 0.186 0.324 0.110
Subjective symptomsb
Dizziness 0 (0.0%) 0 (0.0%) 2 (22.2%) 0.002
OH, orthostatic hypotension; iRBD, idiopathic rapid eye movement sleep behavior disorder; BP, blood pressure; PR, pulse rate.
Results are presented with mean ± standard deviation or percentage in parentheses.
One-way analysis of variance (ANOVA) for systolic BP, diastolic BP and PR, or Kruskal-Wallis for nominal variables are conducted.
p < 0.05 was considered significant. Significant values are given in bold.
Effect sizes (Cohen’s d) are shown for pairwise difference.
aOne-way ANOVA and Tukey’s post-hoc analysis with Bonferroni correction for multiple comparison of three time points.
bChi-square test.
TABLE 3 | Results of heart rate variability analysis during segment 2 and comparison among healthy controls, OH (–) iRBD, and OH (+) iRBD groups.
Effect sizes (r)
HC OH (–) iRBD OH (+) iRBD HC– HC– OH (–) iRBD–
(n = 42) (n = 12) (n = 9) p Pairwise differences OH (–) iRBD OH (+) iRBD OH (+) iRBD
Time-domain analysis
SDNN (ms) 34.9 (20.5) 21.0 (11.8) 13.8 (10.7) <0.001 HC > OH (–) iRBD = OH (+) iRBD 0.477 0.597 0.380
RMSSD (ms) 19.9 (12.7) 13.9 (3.7) 9.5 (11.8) 0.003 HC > OH (–) iRBD = OH (+) iRBD 0.364 0.358 0.132
pNN50 (%) 1.14 (3.78) 0.00 (0.97) 0.60 (0.71) 0.010 HC > OH (–) iRBD 0.370 0.257 0.065
Poincaré plots
SD1 (ms) 13.58 (6.44) 9.53 (3.53) 6.76 (8.32) 0.003 HC > OH (–) iRBD = OH (+) iRBD 0.367 0.351 0.588
SD2 (ms) 46.9 (30.4) 27.4 (16.6) 17.6 (12.8) <0.001 HC > OH (–) iRBD = OH (+) iRBD 0.471 0.602 0.349
SD1/SD2 0.287 (0.112) 0.300 (0.254) 0.463 (0.172) 0.071 N/A 0.132 0.318 0.178
HC, healthy control; iRBD, idiopathic rapid eye movement sleep behavior disorder; OH, orthostatic hypotension; SDNN, standard deviation of all N–N intervals; RMSSD, root mean
square of successive differences; pNN50, percentage of successive RR intervals that differ by more than 50ms; SD1, standard deviation 1; SD2, standard deviation 2.
Results are presented with median (interquartile range).
Kruskal-Wallis test was conducted and post-hoc Mann-Whitney test followed by Bonferroni correction were used.
p < 0.05 was considered significant. Significant values are given in bold.
Effect sizes (r) are shown for pairwise difference.
of SD1 and SD2 than those of the HC group (Table 3). In the OH
(+) iRBD group, the Poincaré plot showed a narrow distribution
as well as the OH (–) iRBD group (Figure 6C); in addition, the
median of SD1 and SD2 were much smaller than those of the HC
group (Table 3).
These results indicated that changes in HRV due to
autonomic dysfunction may appear even in the supine position
before standing, and iRBD patients, especially OH (+)
iRBD patients, had smaller values of HRV indices than the
HC group.
Relationship Between OH (+/–) and HRV
Indices
The multiple logistic regression analysis for OH (+/–) was
performed using HRV indices during segment 2. We identified
SD2 and pNN50 associated with OH (+/–) with the minimal
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FIGURE 6 | Poincaré plots during segment 2 in supine position of (A) a healthy control subject, (B) an OH (–) iRBD subject, and (C) an OH (+) iRBD subject. The
Poincaré plot was based on a simple scatter of plots where the x value is the nth RRI and its corresponding y value is (n+ 1)th RRI. (A) RRI plots were sparsely
distributed between 900 and 1,050ms. The distribution approximates a 45-degree tilted oval. (B) RRI plots were densely distributed between 840 and 920ms. Both
SD1 and SD2 were smaller than (A). (C) RRI plots were closely distributed between 890 and 940ms. SD1 and SD2 were smaller than (A), in particular, SD2 was only
∼40% of (A). OH, orthostatic hypotension; iRBD, idiopathic rapid eye movement sleep behavior disorder; RRI, R–R intervals; HR, heart rate; SD1, standard deviation
1; SD2, standard deviation 2.
value of BIC (p = 0.012). In this model, the AUC of the ROC
curve was 0.840, and the sensitivity of OH (+) was 1.000, and the
specificity of OH (–) was 0.583 (Figure 7). The cutoff values of
SD2 and pNN50 were 17.6 and 0.69, respectively.
The same procedures were conducted for segment 1 and the
whole period. SD2 and pNN50 were also associated with OH
(+/–) with the minimal values of BIC in segment 1 and the
whole period (p = 0.008, 0.005, respectively). In the segment
1 model (Supplementary Figure 1), the AUC of the ROC curve
was 0.870, the sensitivity of OH (+) was 0.778, and the specificity
of OH (–) was 0.917. The cutoff values of SD2 and pNN50
were 12.9 and 0.00, respectively. In the whole period model
(Supplementary Figure 2), the AUC of the ROC curve was 0.870,
the sensitivity of OH (+) was 0.889, and the specificity of OH (–)
was 0.750. The cutoff values of SD2 and pNN50 were 21.0 and
0.12, respectively.
DISCUSSION
Orthostatic hypotension is a prominent symptom not only in
neurodegenerative diseases such as PD, DLB, and MSA, but also
in iRBD. It is important to find indicators of autonomic nerve
activities associated with OH in order to prevent unintended falls.
Dahms et al. conducted the orthostatic challenge test on patients
with iRBD and healthy subjects (43), and they reported that 20
patients with iRBD showed significantly greater decrease in both
sBP and dBP after standing than healthy controls; however, the
decrease rate thereof was not clear. Miyamoto et al. reported
that cardiac 123I-MIBG uptake decreased in patients with iRBD,
which indicates cardiac sympathetic denervation (27, 28). In
addition, the HRV data of iRBD patients were different from
those of HC (30, 31). Thus, we aimed to investigate connections
between rapid changes in HRV in the supine position and the
OH occurrence.
FIGURE 7 | Receiver operating characteristic curve of heart rate variability
during segment 2 for the detection of orthostatic hypotension. The ROC curve
with the AUC of 0.840 is shown (p = 0.012). The sensitivity to OH (+) is 1.000,
and the specificity to OH (–) is 0.583. The optimal cutoff point is pNN50 of
0.69 and SD2 of 17.6. ROC, receiver operating characteristic; AUC, area
under the curve; OH (+), orthostatic hypotension-positive; OH (–), orthostatic
hypotension-negative; pNN50, percentage of successive RR intervals that
differ by more than 50ms; SD2, standard deviation 2.
Conventional time-domain and frequency-domain analyses
have been used for HRV analysis in previous studies. Frequency-
domain analysis, in particular, has been adopted for diagnosing
the severity of autonomic dysfunction; however, the use of
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frequency-domain analysis is not appropriate for older people
because frequency-domain analysis is significantly affected by
arrhythmia and most older people have PVC and PAC (57, 58).
In addition, it is difficult for conventional frequency-domain
analysis to capture rapid changes in the autonomous nerve
activities since it usually requires 2–5min of RRI data. In order
to deal with these problems, we adopted a robust HRV analysis
method: a time-domain analysis and Poincaré plots for short-
term HRV analysis after adopting the Hampel filter and the
quotient filter for modifying arrhythmia appropriately.
Previous studies about the relationship between iRBD and the
autonomic dysfunction mainly focused on nocturnal HRV data
collected from PSG; however, there are some reports about HRV
analysis using the RRI data collected during daytime. Rocchi et al.
and Dahms found autonomic dysfunction in iRBD patients by
analyzing HRV data collected during postural changes (43, 70).
We also performed the orthostatic challenge test between 2
p.m. and 4 p.m. to investigate daytime changes in autonomic
nerve activities.
It has been reported that HRV during rest is related to
the severity of autonomic dysfunction. Diabetic autonomic
dysfunction is related to increases in heart rate and RRI variations
in the rest condition (71, 72). These indicate that HRV during
rest, as well as during postural changes, may be useful for
evaluating autonomic dysfunction. In addition, Sannino et al.
tried to predict decreases in BP of young, healthy people after
standing (56).
Our experiments revealed two important findings regarding
HRV. The first was that short term HRV before standing was
found to represent autonomic dysfunction in patients with iRBD.
SDNN, RMSSD, pNN50, SD1, and SD2 differed in comparison
in the three groups (Table 3). It is noteworthy that the HRV
indices of iRBD patients in the supine position as well as in the
standing position were different from those of the HC group,
which is a new finding of this study. These results show that
physiological RRI fluctuations are reduced in both of OH (–) and
OH (+) iRBD patients (Figure 6), indicating sympathetic and
the parasympathetic nervous dysfunction. In particular, SDNN
and SD2 significantly differed from the OH (+) iRBD and HC
groups with large effect sizes, thus OH (+) iRBD patients were
indicated to have severe autonomic dysfunction compared toHC.
Decreases in HRV indices in OH (–) and OH (+) iRBD are in
good agreement with previous studies (30, 31).
The second finding is that the combination of HRV indices
showed the possibility of predicting OH. Multivariate logistic
regression analysis for OH (–) and OH (+) iRBD patients using
HRV indices presented a good model and ROC curve (Figure 7).
HRV indices may reflect the severity of autonomic dysfunction
in iRBD patients, which may have led to the relationship between
HRV indices and OH. These findings were obtained by the
analysis of HRV during segment 2; similar results were obtained
by the analysis of HRV during segment 1 and the whole period
(Supplementary Table 1, Supplementary Figures 1, 2).
Our results are of clinical importance in terms of showing the
possibility that OH of older people can be predicted using only
HRV data in the supine position without an orthostatic challenge
test, which could improve the efficiency and safety of testing.
However, several steps are required for the clinical application of
OH detection by HRV indices. Since the number of OH patients
were limited in this study, we performed a multivariate logistic
regression analysis for only the construction of models. In the
future, it is needed to validate the current model. Besides there
are issues to be addressed to meet the clinical needs, such as
whether using only the HRV indices is enough for OH detection
or whether a combination of the OH questionnaire and the HRV
indices is useful. A new device that can predict the occurrence
of a fall can thereby be realized, since a wearable device for
measuring RRI and calculating HRV in real-time has already
been developed, which would contribute to preventing the falls
of older people.
There were two benefits of recruiting iRBD patients in this
study. The first was that the evaluation of autonomic dysfunction
in the whole population of iRBD patients [OH (–) and OH
(+) iRBD] was carried out, and the second was that we were
able to perform an analysis to detect severe cases of autonomic
dysfunction [OH (+) iRBD group]. iRBD patients have a high
rate of autonomic dysfunction, and the degree of autonomic
dysfunction was considered to be graded from mild to severe.
Since PD, DLB, and MSA are associated with severe autonomic
dysfunction, and most of the iRBD patients phenoconvert to
PD, DLB, and MSA over a long period of time (14, 15, 20),
patients with iRBD were thought to have various degrees of
autonomic dysfunction. In fact, in this study, iRBD patients
were split approximately halfway between OH (–) and OH (+),
and there were significant decreases in BP after standing and
decreases in HRV indices during the supine position in the OH
(–) and OH (+) iRBD groups compared to HC (Tables 2, 3).
Therefore, the recruitment of iRBD patients, who were diagnosed
with autonomic dysfunction and had had its severity graded, was
consistent with the purpose of this study.
Demographics of the patients with iRBD included in our
experiments were not much different from previous studies (73),
although previous reports on OH in iRBD patients vary widely
in their testing methods and results. Lee reported that 59% (10
of 17) of patients with iRBD displayed OH during the tilt test,
and it was confirmed that 94% of patients had some autonomic
dysfunction through a composite autonomic severity score which
comprehensively evaluates autonomic nervous dysfunction (74).
In Fraucher’s study, only 13% (2 of 15) of patients with iRBD
had OH; however, the composite autonomic scoring scale was
significantly higher in patients with iRBD than healthy controls
(75). A recent multicenter study found that 29% (156 of 531)
of patients with iRBD had orthostatic symptoms (26). Although
these studies have reported that most patients with iRBD have
autonomic dysfunction, the proportion of OH in iRBD patients
in these studies was different from each other. This variation
might be explained by the age of the participants, duration of
iRBD, the prevalence of cardiovascular disease, and experimental
techniques. On the other hand, 43% (9 of 21) of patients with
iRBD displayed OH (Tables 1, 2) in this study, which is a modest
prevalence in comparison with these previous studies. Patients
with iRBD is prevalent in older males (76), and the population of
this study matched the epidemiological characteristics of iRBD.
In addition, patients with dementia were excluded, and we
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confirmed that their MMSE scores exceeded the cutoff. It is also
consistent with previous reports, in which only iRBD patients
with no apparent cognitive impairment were included (73). Thus,
it is concluded that our study has external validity.
On the other hand, the RBDSQ-J score of our population was
lower than in the previous report (53), and the average disease
duration was rather long: ∼10 years after symptom emergence.
The RBDSQ-J score may have been low due to the long disease
duration of iRBD (77). According to a longitudinal observational
study of patients with a long disease duration of iRBD, almost
all subjects showed multiple features of neurodegeneration
including autonomic dysfunction after a follow-up of at least
10 years (19). Therefore, the participants in the present study
with a long disease duration are an appropriate population for
evaluating autonomic dysfunction.
The time of the experiment, the last meal, and the temperature
and humidity in the laboratory were controlled to reduce
their effects on the autonomic activities. The participants
were instructed to stop consuming alcohol and tobacco the
night before. However, autonomic activities in daily life are
affected by various factors such as circadian rhythms and
diet as well as alcohol, tobacco, and temperature (40, 42,
78–80). Niu et al. demonstrated significant changes in HRV
after hemodialysis in elderly patients with diabetes (81). Thus,
changes in the autonomic nervous activities, including HRV
and BP fluctuations in daily life, may be greater than the
results of this study. In order to accurately identify the
indicators of OH occurrence, it is necessary to record the
amount of daily alcohol and water consumption, the time of
meal, temperature, humidity, and other factors as well as the
RRI data. Since our device can measure RRI continuously
for 24 h, we will perform additional experiments in a daily-
life setting.
Because Xie et al. suggested that cognitive impairment-
related gait disorders occur while walking in daily life among
patients with amnestic mild cognitive impairment (82),
comprehensive assessments of falls including the autonomic
nervous functions and cognitive impairment-related gait
disorders are also needed. In addition, from the viewpoint
of fall prevention, we should account for orthostatic cerebral
hypoperfusion syndromes, which are possible underlying
pathophysiologies of orthostatic dizziness without orthostatic
hypotension (83).
The limitations of this research include medication
and comorbidities; although older people regularly use
blood pressure-related medications due to hypertension or
complications of angina, our study did not control for these
medications and comorbidities. Some patients took calcium
channel blockers, ACE and AT II inhibitors, and organic
nitrates. There were significant differences in the proportion
of myocardial infarction comorbidity and the use of ACE
and AT II inhibitors (Table 1). To address this problem, we
performed an analysis related to HRV after excluding patients
with the comorbidity of myocardial infarction or the use of
ACE and AT II inhibitors. After excluding one OH (–) iRBD
patient and two OH (+) iRBD patients, HRV indices were
calculated and the multivariate logistic regression analysis was
performed (Supplementary Table 2, Supplementary Figure 3).
The results of the analysis showed similar results in Table 3 and
Figure 7. Although the patients with other comorbidities or
medication use should have been excluded from the analysis,
we could not perform the analysis due to the reduced sample
size. The undeniable influence of some comorbidities and
medication is a limitation of this study. In order to assess
the autonomic dysfunction without drug-related effects, it
was necessary to instruct the subjects to discontinue these
medications. Dahms performed the orthostatic challenge test
after having the patients stop taking their regular medications
(43); however, it would not have been appropriate for the patients
to stop taking their regular medication for our experiments,
because our purpose was to identify indicators of risk of falls in
daily life.
Another limitation was the ratio of male to female in the
HC group. In this study, there were more females than males
in HC (female: 62%), although the number of males was more
significant than that of females in the patient group reflecting
the characteristics of RBD prevalence. There was the possibility
that this gender difference might affect HRV and decreases in
BP. To address this issue, we prepared randomized HC samples
with the number of HC adjusted for the ratio of males to
females in the iRBD groups (female: 19%) because the sample
size of iRBD was smaller than that of HC. Namely, of the 26
HC females, we randomly selected 4 females 10 times, then
created a sample of HC (16 males and 4 females) 10 times.
The mean or median of variables of the 10 randomized samples
of the 20 HC, whose male-to-female ratio was matched to
the iRBD, are shown in Supplementary Table 3. Although the
comorbidities with arterial hypertension and diabetes mellitus
and the rate of medication use of calcium channel blockers
and ACE and AT II inhibitors were higher than the original
HC group (Table 1), the values of BP and PR and the
HRV indices were not markedly different from those of the
original HC group (Tables 2, 3). Therefore, we believe that
the gender ratio in HC does not largely affect the results of
this study.
CONCLUSION
In this study, iRBD patients showed significant decreases in BP
after standing and significant decreases in HRV indices during
a supine position compared to HC. The combination of HRV
indices would predict subsequent OH in iRBD patients. Our
results are clinically useful in terms of showing the possibility that
OH can be predicted without an orthostatic challenge test using
only HRV data in the supine position, which could improve the
efficiency and the safety of testing. Future studies are required
to develop a system that can predict OH before standing up by
analyzing HRV in real-time.
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Supplementary Figure 1 | Receiver operating characteristic curve of heart rate
variability during segment 1 for the detection of orthostatic hypotension. The ROC
curve with the AUC of 0.870 is shown (p = 0.008). The sensitivity to OH (+) is
0.778, and the specificity to OH (–) is 0.917. The optimal cutoff point is pNN50 of
0.00 and SD2 of 12.9. ROC, receiver operating characteristic; AUC, area under
the curve; OH (+), orthostatic hypotension-positive; OH (–), orthostatic
hypotension-negative; pNN50, percentage of successive RR intervals that differ
by more than 50ms; SD2, standard deviation 2.
Supplementary Figure 2 | Receiver operating characteristic curve of heart rate
variability during the whole period for the detection of orthostatic hypotension. The
ROC curve with the AUC of 0.870 is shown (p = 0.005). The sensitivity to OH (+)
is 0.889, and the specificity to OH (–) is 0.750. The optimal cutoff point is pNN50
of 0.12 and SD2 of 21.0. ROC, receiver operating characteristic; AUC, area under
the curve; OH (+), orthostatic hypotension-positive; OH (–), orthostatic
hypotension-negative; pNN50, percentage of successive RR intervals that differ
by more than 50ms; SD2, standard deviation 2.
Supplementary Figure 3 | Receiver operating characteristic curve of heart rate
variability during segment 2 for the detection of orthostatic hypotension, excluding
the patients with a history of myocardial infarction or use of
angiotensin-converting-enzyme or angiotensin II type 1 inhibitors. The ROC curve
with the AUC of 0.818 is shown (p = 0.023). The sensitivity to OH (+) is 1.000,
and the specificity to OH (–) is 0.636. The optimal cutoff point is pNN50 of 0.71
and SD2 of 23.9. ROC, receiver operating characteristic; AUC, area under the
curve; OH (+), orthostatic hypotension-positive; OH (–), orthostatic
hypotension-negative; pNN50, percentage of successive RR intervals that differ
by more than 50ms; SD2, standard deviation 2.
Supplementary Table 1 | Results of heart rate variability analysis during segment
1 and the whole period and comparison among healthy controls, OH (–) iRBD,
and OH (+) iRBD groups.
Supplementary Table 2 | Results of heart rate variability analysis during segment
2 of OH (–) iRBD and OH (+) iRBD groups without history of myocardial infarction
or use of angiotensin-converting-enzyme or angiotensin II type 1 inhibitors.
Supplementary Table 3 | Demographic data and results of the study of randomly
sampled, sex ratio-adjusted healthy control.
REFERENCES
1. Tilvis RS, Hakala SM, Valvanne J, Erkinjuntti T. Postural hypotension
and dizziness in a general aged population: a four-year follow-
up of the Helsinki Aging Study. J Am Geriatr Soc. (1996)
44:809–14. doi: 10.1111/j.1532-5415.1996.tb03738.x
2. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni
I, et al. Consensus statement on the definition of orthostatic hypotension,
neurally mediated syncope and the postural tachycardia syndrome. Clin
Auton Res. (2011) 21:69–72. doi: 10.1007/s10286-011-0119-5
3. Frith J. Diagnosing orthostatic hypotension: a narrative review of the
evidence. Br Med Bull. (2015) 115:123–34. doi: 10.1093/bmb/ldv025
4. Mol A, Bui Hoang PTS, Sharmin S, Reijnierse EM, van Wezel RJA,
Meskers CGM, et al. Orthostatic hypotension and falls in older adults: a
systematic review and meta-analysis. J Am Med Dir Assoc. (2019) 20:589–97
e585. doi: 10.1016/j.jamda.2018.11.003
5. Low PA, Tomalia VA. Orthostatic hypotension: mechanisms, causes,
management. J Clin Neurol. (2015) 11:220–6. doi: 10.3988/jcn.2015.
11.3.220
6. Raj SR. What is the optimal orthostatic stress to diagnose orthostatic
hypotension?Clin Auton Res. (2005) 15:67–8. doi: 10.1007/s10286-005-0265-8
7. Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli
A, et al. 2018 ESC Guidelines for the diagnosis and management
of syncope. Eur Heart J. (2018) 39:1883–948. doi: 10.5603/KP.2018.
0161
8. Juraschek SP, Daya N, Rawlings AM, Appel LJ, Miller ER 3rd,
Windham BG, et al. Association of history of dizziness and long-
term adverse outcomes with early vs later orthostatic hypotension
assessment times in middle-aged adults. JAMA Intern Med. (2017)
177:1316–23. doi: 10.1001/jamainternmed.2017.2937
9. Shibao C, Lipsitz LA, Biaggioni I. Evaluation and treatment of
orthostatic hypotension. J Am Soc Hypertens. (2013) 7:317–24.
doi: 10.1016/j.jash.2013.04.006
10. Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning
GK. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and
management. J Neurol. (2013) 260:2212–9. doi: 10.1007/s00415-012-6736-7
11. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral
disorders of human REM sleep: a new category of parasomnia. Sleep. (1986)
9:293–308. doi: 10.1093/sleep/9.2.293
12. Plazzi G, Corsini R, Provini F, Pierangeli G, Martinelli P, Montagna P, et al.
REM sleep behavior disorders in multiple system atrophy. Neurology. (1997)
48:1094–7. doi: 10.1212/WNL.48.4.1094
13. Gagnon JF, BedardMA, Fantini ML, Petit D, Panisset M, Rompre S, et al. REM
sleep behavior disorder and REM sleep without atonia in Parkinson’s disease.
Neurology. (2002) 59:585–9. doi: 10.1212/WNL.59.4.585
14. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson’s
disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol. (2004)
17:146–57. doi: 10.1177/0891988704267465
15. Boeve BF. REM sleep behavior disorder: updated review of the core features,
the REM sleep behavior disorder-neurodegenerative disease association,
Frontiers in Neurology | www.frontiersin.org 13 November 2020 | Volume 11 | Article 567984
Sumi et al. Resting HRV Associated With OH
evolving concepts, controversies, and future directions. Ann N Y Acad Sci.
(2010) 1184:15–54. doi: 10.1111/j.1749-6632.2009.05115.x
16. Plomhause L, Dujardin K, Duhamel A, Delliaux M, Derambure P,
Defebvre L, et al. Rapid eye movement sleep behavior disorder in
treatment-naive Parkinson disease patients. Sleep Med. (2013) 14:1035–
7. doi: 10.1016/j.sleep.2013.04.018
17. Poryazova R, Oberholzer M, Baumann CR, Bassetti CL. REM sleep behavior
disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep
Med. (2013) 9:55–9A. doi: 10.5664/jcsm.2340
18. Fantini ML, Ferini-Strambi L, Montplaisir J. Idiopathic REM sleep behavior
disorder: toward a better nosologic definition. Neurology. (2005) 64:780–
6. doi: 10.1212/01.WNL.0000152878.79429.00
19. Yao C, Fereshtehnejad SM, Dawson BK, Pelletier A, Gan-Or Z, Gagnon JF,
et al. Longstanding disease-free survival in idiopathic REM sleep behavior
disorder: is neurodegeneration inevitable? Parkinsonism Relat Disord. (2018)
54:99–102. doi: 10.1016/j.parkreldis.2018.04.010
20. Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L. The risk of
neurodegeneration in REM sleep behavior disorder: a systematic review
and meta-analysis of longitudinal studies. Sleep Med Rev . (2019) 43:37–
46. doi: 10.1016/j.smrv.2018.09.008
21. McCarter SJ, Gehrking TL, St Louis EK, Suarez MD, Boeve BF, Silber MH,
et al. Autonomic dysfunction and phenoconversion in idiopathic REM sleep
behavior disorder. Clin Auton Res. (2020) 30:207–13. doi: 10.1007/s10286-
020-00674-5
22. Mendoza-Velasquez JJ, Flores-Vazquez JF, Barron-Velazquez
E, Sosa-Ortiz AL, Illigens BW, Siepmann T. Autonomic
dysfunction in alpha-synucleinopathies. Front Neurol. (2019)
10:363. doi: 10.3389/fneur.2019.00363
23. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic
dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord. (2004)
19:1306–12. doi: 10.1002/mds.20153
24. Iranzo A, Santamaria J, Tolosa E. Idiopathic rapid eye movement
sleep behaviour disorder: diagnosis, management, and the
need for neuroprotective interventions. Lancet Neurol. (2016)
15:405–19. doi: 10.1016/S1474-4422(16)00057-0
25. Barone DA, Henchcliffe C. Rapid eye movement sleep behavior disorder
and the link to alpha-synucleinopathies. Clin Neurophysiol. (2018) 129:1551–
64. doi: 10.1016/j.clinph.2018.05.003
26. Postuma RB, Iranzo A, Hu M, Hogl B, Boeve BF, Manni R, et al.
Risk and predictors of dementia and parkinsonism in idiopathic REM
sleep behaviour disorder: a multicentre study. Brain. (2019) 142:744−59.
doi: 10.1093/brain/awz030
27. Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K.
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior
disorder. Neurology. (2006) 67:2236–8. doi: 10.1212/01.wnl.0000249313.25
627.2e
28. Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M,
Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying
neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep.
(2008) 31:717–23. doi: 10.1093/sleep/31.5.717
29. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al.
Power spectral analysis of heart rate and arterial pressure variabilities as a
marker of sympatho-vagal interaction in man and conscious dog. Circ Res.
(1986) 59:178–93. doi: 10.1161/01.RES.59.2.178
30. Postuma RB, Lanfranchi PA, Blais H, Gagnon JF, Montplaisir JY. Cardiac
autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov
Disord. (2010) 25:2304–10. doi: 10.1002/mds.23347
31. Postuma RB, Montplaisir J, Lanfranchi P, Blais H, Rompre S, Colombo R,
et al. Cardiac autonomic denervation in Parkinson’s disease is linked to REM
sleep behavior disorder. Mov Disord. (2011) 26:1529–33. doi: 10.1002/mds.
23677
32. Sauvageot N, Vaillant M, Diederich NJ. Reduced sympathetically
driven heart rate variability during sleep in Parkinson’s disease:
a case-control polysomnography-based study. Mov Disord. (2011)
26:234–40. doi: 10.1002/mds.23479
33. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology
and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol.
(2011) 26(Suppl. 1):S1–58. doi: 10.1007/s10654-011-9581-6
34. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D,
et al. Diagnosis and management of dementia with Lewy bodies: fourth
consensus report of the DLB Consortium. Neurology. (2017) 89:88–100.
doi: 10.1212/WNL.0000000000004058
35. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ,
et al. Second consensus statement on the diagnosis of multiple system atrophy.
Neurology. (2008) 71:670–6. doi: 10.1212/01.wnl.0000324625.00404.15
36. Iranzo A, Santamaria J. Severe obstructive sleep apnea/hypopnea
mimicking REM sleep behavior disorder. Sleep. (2005) 28:203–
6. doi: 10.1093/sleep/28.2.203
37. Teman PT, Tippmann-Peikert M, Silber MH, Slocumb NL, Auger
RR. Idiopathic rapid-eye-movement sleep disorder: associations with
antidepressants, psychiatric diagnoses, and other factors, in relation to age of
onset. Sleep Med. (2009) 10:60–5. doi: 10.1016/j.sleep.2007.11.019
38. Piskorski J, Guzik P. Filtering Poincaré plots. Comput Methods Sci Technol.
(2005) 11:39–48. doi: 10.12921/cmst.2005.11.01.39-48
39. Allen DP. A frequency domain Hampel filter for blind rejection of sinusoidal
interference from electromyograms. J Neurosci Methods. (2009) 177:303–
10. doi: 10.1016/j.jneumeth.2008.10.019
40. Young HA, Cousins AL,Watkins HT, Benton D. Is the link between depressed
mood and heart rate variability explained by disinhibited eating and diet? Biol
Psychol. (2017) 123:94–102. doi: 10.1016/j.biopsycho.2016.12.001
41. Yamasaki Y, Kodama M, Matsuhisa M, Kishimoto M, Ozaki
H, Tani A, et al. Diurnal heart rate variability in healthy
subjects: effects of aging and sex difference. Am J Physiol. (1996)
271:H303–10. doi: 10.1152/ajpheart.1996.271.1.H303
42. Young HA, Benton D. Heart-rate variability: a biomarker to study the
influence of nutrition on physiological and psychological health? Behav
Pharmacol. (2018) 29:140–51. doi: 10.1097/FBP.0000000000000383
43. Dahms C, Guenther A, Schwab M, Schultze T, Nowack S, Hoyer
D, et al. Dysautonomia in prodromal alpha-synucleinopathy: peripheral
versus central autonomic degeneration. Eur J Neurol. (2016) 23:878–
90. doi: 10.1111/ene.12957
44. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ.
Hemodynamic regulation: investigation by spectral analysis. Am J Physiol.
(1985) 249:H867–75. doi: 10.1152/ajpheart.1985.249.4.H867
45. Bekheit S, Tangella M, el-Sakr A, Rasheed Q, Craelius W, El-Sherif N. Use of
heart rate spectral analysis to study the effects of calcium channel blockers
on sympathetic activity after myocardial infarction. Am Heart J. (1990)
119:79–85. doi: 10.1016/S0002-8703(05)80085-7
46. Cook JR, Thomas Bigger J, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM.
Effect of atenolol and diltiazem on heart period variability in normal persons.
J Am Coll Cardiol. (1991) 17:480–4. doi: 10.1016/S0735-1097(10)80119-6
47. Halliwill JR, Billman GE. Effect of general anesthesia on cardiac vagal tone.
Am J Physiol. (1992) 262:H1719–24. doi: 10.1152/ajpheart.1992.262.6.H1719
48. Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS.
Heart rate variability: a review. Med Biol Eng Comput. (2006) 44:1031–
51. doi: 10.1007/s11517-006-0119-0
49. Lanier JB, Mote MB, Clay EC. Evaluation and management of orthostatic
hypotension. Am Fam Physician. (2011) 84:527–36. Available online at:
https://www.aafp.org/afp/2011/0901/afp20110901p527.pdf
50. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatric Res.
(1975) 12:189–98. doi: 10.1016/0022-3956(75)90026-6
51. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner
M, Oertel WH. The REM sleep behavior disorder screening
questionnaire–a new diagnostic instrument. Mov Disord. (2007)
22:2386–93. doi: 10.1002/mds.21740
52. Skorvanek M, Feketeova E, Kurtis MM, Rusz J, Sonka K. Accuracy
of rating scales and clinical measures for screening of rapid eye
movement sleep behavior disorder and for predicting conversion to
Parkinson’s disease and other synucleinopathies. Front Neurol. (2018)
9:376. doi: 10.3389/fneur.2018.00376
53. Miyamoto T, Miyamoto M, Iwanami M, Kobayashi M, Nakamura M,
Inoue Y, et al. The REM sleep behavior disorder screening questionnaire:
validation study of a Japanese version. Sleep Med. (2009) 10:1151–
4. doi: 10.1016/j.sleep.2009.05.007
54. Yamakawa T, Fujiwara K, Miyajima M, Abe E, Kano M, Ueda Y. Real-
time heart rate variability monitoring employing a wearable telemeter and
Frontiers in Neurology | www.frontiersin.org 14 November 2020 | Volume 11 | Article 567984
Sumi et al. Resting HRV Associated With OH
a smartphone. In: Signal and Information Processing Association Annual
Summit and Conference (APSIPA), 2014 Asia-Pacific. (2014). p. 1–4.
55. Fujiwara K, Miyajima M, Yamakawa T, Abe E, Suzuki Y, Sawada Y, et al.
Epileptic seizure prediction based on multivariate statistical process control
of heart rate variability features. IEEE Trans Biomed Eng. (2016) 63:1321–
32. doi: 10.1109/TBME.2015.2512276
56. Sannino G, Melillo P, Stranges S, De Pietro G, Pecchia L. Short
term heart rate variability to predict blood pressure drops due to
standing: a pilot study. BMC Med Inform Decis Mak. (2015) 15(Suppl.
3):S2. doi: 10.1186/1472-6947-15-S3-S2
57. Conen D, Adam M, Roche F, Barthelemy JC, Felber Dietrich
D, Imboden M, et al. Premature atrial contractions in the
general population: frequency and risk factors. Circulation. (2012)
126:2302–8. doi: 10.1161/CIRCULATIONAHA.112.112300
58. Callans DJ. Premature ventricular contraction-induced cardiomyopathy.
Arrhythm Electrophysiol Rev. (2017) 6:153–5. doi: 10.15420/aer.2017/6.4/EO1
59. Brennan M, Palaniswami M, Kamen P. Do existing measures of Poincare
plot geometry reflect nonlinear features of heart rate variability? IEEE Trans
Biomed Eng. (2001) 48:1342–7. doi: 10.1109/10.959330
60. Kamen PW, Krum H, Tonkin AM. Poincare plot of heart rate variability
allows quantitative display of parasympathetic nervous activity in humans.
Clin Sci. (1996) 91:201–8. doi: 10.1042/cs0910201
61. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics
and norms. Front Public Health. (2017) 5:258. doi: 10.3389/fpubh.2017.
00258
62. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from
24-hour electrocardiography and the 2-year risk for sudden death.Circulation.
(1993) 88:180–5. doi: 10.1161/01.CIR.88.1.180
63. Manfrini O, Pizzi C, Trere D, Fontana F, Bugiardini R. Parasympathetic
failure and risk of subsequent coronary events in unstable angina and non-
ST-segment elevation myocardial infarction. Eur Heart J. (2003) 24:1560–
6. doi: 10.1016/S0195-668X(03)00345-2
64. Guzik P, Piskorski J, Krauze T, Schneider R, Wesseling KH, Wykretowicz
A, et al. Correlations between the Poincare plot and conventional heart rate
variability parameters assessed during paced breathing. J Physiol Sci. (2007)
57:63–71. doi: 10.2170/physiolsci.RP005506
65. Hoshi RA, Pastre CM, Vanderlei LC, Godoy MF. Poincare plot indexes of
heart rate variability: relationships with other nonlinear variables. Auton
Neurosci. (2013) 177:271–4. doi: 10.1016/j.autneu.2013.05.004
66. Goshvarpour A, Abbasi A, Goshvarpour A. Indices from lagged
poincare plots of heart rate variability: an efficient nonlinear tool
for emotion discrimination. Australas Phys Eng Sci Med. (2017)
40:277–87. doi: 10.1007/s13246-017-0530-x
67. Cohen J. Statistical Power Analysis for the Behavioral Sciences Second Edition.
Burlington, NJ: Routledge (2013).
68. Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV,
editors. The Handbook of Research Synthesis. New York, NY: Russell Sage
Foundation (1994). p. 231–44.
69. Youden WJ. Index for rating diagnostic tests. Cancer. (1950) 3:32–
5. doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
70. Rocchi C, Placidi F, Liguori C, Del Bianco C, Lauretti B, Diomedi M,
et al. Daytime autonomic activity in idiopathic rapid eye movement
sleep behavior disorder: a preliminary study. Sleep Med. (2018) 52:163–
7. doi: 10.1016/j.sleep.2018.08.023
71. Sacre JW, Jellis CL, Marwick TH, Coombes JS. Reliability of heart rate
variability in patients with type 2 diabetes mellitus. Diabet Med. (2012)
29:e33–40. doi: 10.1111/j.1464-5491.2011.03557.x
72. Tang ZH, Zeng F, Li Z, Zhou L. Association and predictive value
analysis for resting heart rate and diabetes mellitus on cardiovascular
autonomic neuropathy in general population. J Diabetes Res. (2014)
2014:215473. doi: 10.1155/2014/215473
73. Li X, Zhou Z, Jia S, Hou C, ZhengW, Rong P, et al. Cognitive study on Chinese
patients with idiopathic REM sleep behavior disorder. J Neurol Sci. (2016)
366:82–6. doi: 10.1016/j.jns.2016.04.047
74. Lee H, Cho YW, Kim HA. The severity and pattern of autonomic dysfunction
in idiopathic rapid eye movement sleep behavior disorder.Mov Disord. (2015)
30:1843–8. doi: 10.1002/mds.26416
75. Frauscher B, Nomura T, Duerr S, Ehrmann L, Gschliesser V, Wenning
GK, et al. Investigation of autonomic function in idiopathic REM sleep
behavior disorder. J Neurol. (2012) 259:1056–61. doi: 10.1007/s00415-011-
6298-0
76. Postuma RB, Pelletier A, Berg D, Gagnon JF, Escudier F,
Montplaisir J. Screening for prodromal Parkinson’s disease in the
general community: a sleep-based approach. Sleep Med. (2016)
21:101–5. doi: 10.1016/j.sleep.2015.12.016
77. Sumi Y, Matsuo M, Nakabayashi T, Masuda F, Takahashi M, Kanemura
T, et al. Changes in the symptom frequency of rapid eye movement sleep
behavior disorder according to disease duration. Sleep Sci Pract. (2017)
1:16. doi: 10.1186/s41606-017-0017-4
78. Zygmunt A, Stanczyk J. Methods of evaluation of autonomic nervous system
function. Arch Med Sci. (2010) 6:11–8. doi: 10.5114/aoms.2010.13500
79. Buijs RM, Escobar C, Swaab DF. The circadian system and the balance
of the autonomic nervous system. Handb Clin Neurol. (2013) 117:173–
91. doi: 10.1016/B978-0-444-53491-0.00015-8
80. Okada M, Kakehashi M. Effects of outdoor temperature on changes in
physiological variables before and after lunch in healthy women. Int J
Biometeorol. (2014) 58:1973–81. doi: 10.1007/s00484-014-0800-1
81. Niu SW, Huang JC, Chen SC, Lin HY, Kuo IC, Wu PY, et al.
Association between age and changes in heart rate variability after
hemodialysis in patients with diabetes. Front Aging Neurosci. (2018)
10:43. doi: 10.3389/fnagi.2018.00043
82. Xie H, Wang Y, Tao S, Huang S, Zhang C, Lv Z. Wearable sensor-
based daily life walking assessment of gait for distinguishing individuals
with amnestic mild cognitive impairment. Front Aging Neurosci. (2019)
11:285. doi: 10.3389/fnagi.2019.00285
83. Novak P. Orthostatic cerebral hypoperfusion syndrome. Front Aging Neurosci.
(2016) 8:22. doi: 10.3389/fnagi.2016.00022
Conflict of Interest: HK’s laboratory is supported by a donation from Fukuda
Lifetech Co., Ltd., Fukuda Life Tech Keiji Co., Ltd., Tanaka Sleep Clinic, Akita
Sleep Clinic, and Ai Care Co., Ltd. to the Shiga University of Medical Science. HK
received a grant from Merck Sharp & Dohme Corp/MSD K.K. (the Investigator-
Initiated Studies Program). The opinions expressed in this paper are those of
the authors and do not necessarily represent those of Merck Sharp & Dohme
Corp/MSD K.K. KF, TY, and MK participate in Quadlytics Inc.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2020 Sumi, Nakayama, Kadotani, Matsuo, Ozeki, Kinoshita, Goto,
Kano, Yamakawa, Hasegawa-Ohira, Ogawa and Fujiwara. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Neurology | www.frontiersin.org 15 November 2020 | Volume 11 | Article 567984
